Alteco Medical AB engages in the development of medical device for intensive care. Its extracorporeal product, Lipopolysaccharides (LPS) Adsorber, enables to adsorb endotoxin from whole blood for intensive care of the septic patient. The company was founded by Anders Althin in 2002 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company